▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3471 by analyst upside · 2026-09-27
LH
Labcorp Holdings Inc.
Healthcare · Market Cap $25B · P/E 25.6x
ANALYST PRICE TARGET
+11.4%
implied upside to consensus target
Current Price $309.64
Consensus Target $344.81
Bull Target $385.0
Bear Target $293.0
Analysts Covering 16
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
10
Hold
4
Sell
0
52-Week Low $244.52
52-Week High $341.8
YTD Return +24.0%
FUNDAMENTALS
Market Cap $25B
P/E Ratio (TTM) 25.6x
Forward P/E 15.6x
EPS (TTM) $12.08
PEG Ratio 1.21
Dividend Yield 0.93%
Revenue (TTM) $14.3B
Profit Margin 7.0%
52-WEEK RANGE
52-Week Low $244.52
52-Week High $341.8
Current Price $309.64
Bear Target $293.0
Bull Target $385.0
● Now $309.64 ● Target $344.81
TRADING DATA
Avg Volume 736K
YTD Return +24.0%
Analyst Count 16
Consensus Buy
Upside to Target +11.4%
Last Updated 2026-09-27

ANALYST SUMMARY

Labcorp Holdings Inc. (LH) is currently trading at $309.64 with a Wall Street consensus price target of $344.81, implying potential upside of 11.4% over the next 12 months. 16 analysts currently cover LH, with a consensus rating of Buy - 75% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $385.0, while the most cautious has a target of $293.0.

LH operates in the Healthcare sector with a market capitalisation of $25B. The stock is up 24.0% year-to-date and is currently trading near the upper end of its 52-week range of $244.52 – $341.8.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for LH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Truist Securities - Reiterated
Buy → Buy 2026-09-21 Building track record
UBS - Reiterated
Buy → Buy 2026-09-11 33% win rate (6 calls)
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-09-11 Building track record
Piper Sandler - Reiterated
Neutral → Neutral 2026-08-04 14% win rate (7 calls)
JP Morgan - Reiterated
Overweight → Overweight 2026-08-03 43% win rate (7 calls)
Morgan Stanley - Reiterated
Overweight → Overweight 2026-07-31 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-07-31 Building track record
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-07-31 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
60
out of 100
Coverage depth
22/30
Consensus clarity
24/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →